Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 50Rectal Neoplasms 49Colorectal Neoplasms 36Pancreatic Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 9Neoplasm Metastasis 8Stomach Neoplasms 7Ovarian Neoplasms 6Carcinoma, Hepatocellular 6Lymphoma, Large B-Cell, Diffuse 5Gallbladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Bile Duct Neoplasms 5Burkitt Lymphoma 4Appendiceal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Neoplasms 3Fallopian Tube Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Osteosarcoma 2Optic Nerve Glioma 2Neurotoxicity Syndromes 2Neuroectodermal Tumors, Primitive, Peripheral 2Nasopharyngeal Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2

Interventions

Specimen Handling 2Nivolumab 2pembrolizumab 1avelumab 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Fluorouracil 1Diffusion Tensor Imaging 1Capecitabine 1CTLA-4 Antigen 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Turcot syndrome × Oxaliplatin × Clear all
NCT03050814 2021-12-20

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
30 enrolled 15 charts
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡